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Background: Toll-like receptors (TLRs), Coronin-1 and Sp110 are essential factors for the containment of
Mycobacterium tuberculosis infection. The purpose of this study was to investigate the in vivo expression of these
molecules at different stages of the infection and uncover possible relationships between these markers and the
state of the disease.
Methods: Twenty-two patients with active tuberculosis, 15 close contacts of subjects with latent disease, 17 close
contacts of subjects negative for mycobacterium antigens and 10 healthy, unrelated to patients, subjects were
studied. Quantitative mRNA expression of Coronin-1, Sp110, TLRs-1,-2,-4 and -6 was analysed in total blood cells vs
an endogenous house-keeping gene.
Results: The mRNA expression of Coronin-1, Sp110 and TLR-2 was significantly higher in patients with active
tuberculosis and subjects with latent disease compared to the uninfected ones. Positive linear correlation for the
expression of those factors was only found in the infected populations.
Conclusions: Our results suggest that the up-regulation of Coronin-1 and Sp110, through a pathway that also
includes TLR-2 up-regulation may be involved in the process of tuberculous infection in humans. However, further
studies are needed, in order to elucidate whether the selective upregulation of these factors in the infected
patients could serve as a specific molecular marker of tuberculosis.
Background
In the majority of patients, tuberculosis (TB) is typically
found as an airborne disease due to droplet nuclei infec-
tion. In the immuno-competent host, lungs are most
commonly affected in M. Tuberculosis (MTB) infection,
with estimates of 80-87% of lung involvement in sub-
jects with active disease. A similar estimate of 70-90%
has also been observed in immuno-compromised hosts,
such as those with human immuno-deficiency virus
infection (HIV) [1]. A person in close contact with a
smear-positive patient is at maximum risk of being
infected. Studies have shown that the infection rate
among close contacts ranges from 25-50%, even in the
w o r s to v e r - c r o w d e da n ds u b - standard conditions, while
among those infected only a 10% will progress to disease
[2]. Thus, a great portion of close contacts remains
uninfected after exposure and is probably due to the
host’s innate immune system.
The effective antimicrobial action of monocytes/
macrophages against MTB infection consists of a well-
organized antimicrobial machinery, with a large arma-
mentarium of cytotoxic molecules, including Toll-like
receptors, phagosome-lysosome function and the
recently described tuberculosis resistance genes that are
considered integral parts of this mechanism [3,4].
Toll-like receptors (TLRs) are a family of proteins that
play a key role in the innate immune response to
infectious agents through their ability to discriminate
conserved microbial structures, known as pathogen-
associated molecular patterns (PAMPs), from self. TLRs
recognition of PAMPs, such as lipopolysaccharide (LPS),
initiates signal transduction through the NF-kB pathway.
Nuclear translocation of NF-kB induces transcription of
pro-inflammatory cytokine genes essential to mounting
ap r o t e c t i v ei m m u n er e s p o n s ea n dh o s td e f e n c e[ 5 ] .
TLRs’ stimulation in macrophages has been shown to
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MAP kinase in a MyD88 dependent signalling pathway
[6,7]. Pathogen associated molecular pattern signatures
for pathogenic mycobacteria include, CpG DNA, 19 kDa
lipoprotein, lipoarabidomannan and mannosylated phos-
photidylinositol (PIM) [8]. TLRs have been reported to
participate in the interaction of pathogenic mycobacteria
or in their extracellular products in mice and humans.
In particular, TLR-2, in association with TLR-1, TLR-6
and TLR-4, has been implicated as a receptor involved
in the recognition of mycobacterial antigens and acti-
vation of macrophages and dendritic cells (DCs) [9].
Furthermore, TLRs are essential in the killing process
of intracellular mycobacteria by human macrophages
through the induction of the antimicrobial peptide
cathelicidin [10]. In addition, it has recently been
shown that TLRs’ non-synonymous polymorphisms are
significantly associated with tuberculosis disease in
humans [11].
Pathogenic mycobacteria have evolved a unique strat-
egy to survive intracellularly within macrophages. They
modulate phagosome maturation to prevent the fusion
of endosomes with lysosomes. The block of phagolyso-
some biogenesis has been proposed to play a central
role in the pathogenesis of the mycobacterium [12]. The
prolonged survival of M. tuberculosis within their mam-
malian host cells suggested that these pathogens, apart
from producing virulence factors such as phosphatase
SapM and protein kinase PknG, have evolved mechan-
isms to utilise host molecules for their own survival
[3,13]. An analysis of the protein composition of myco-
bacterial phagosome showed the exclusive presence of a
protein that was strongly retained on phagosomes har-
bouring live mycobacteria [13,14]. This protein, initially
named TACO (for tryptophan-aspartatecontaining coat
protein) is now referred as Coronin-1. Coronin-1 is a
member of the WD repeatcontaining protein family of
coronins. The founding member of this protein family
was identified in the amoeba Dictyostelium discoideum
and is involved in the regulation of actin-based
dynamics [15].
In mammalian cells up to seven coronin isoforms have
been identified and were thought to regulate F-actin-
dependent cytoskeleton [16]. Recent data indicate that
Coronin-1 is essential for the survival of live mycobac-
teria into monocytes/macrophages, because this protein
arrests the maturation of phagosome to phagolysosome.
Coronin-1 is specifically restricting phagosomes contain-
ing live mycobacteria from entering the lysosomal path-
way by regulating a calcium- dependent signalling
process, which activates the calcium-dependent phos-
phatase calcineurin. This enzyme is responsible for the
blocking effect of phagosome-lysosome fusion. In the
absence of Coronin-1, calcineurin cannot be activated
which results in lysosomal transfer and death of interna-
lized mycobacteria. Similar results were also retrieved
with calcineurin blockers, such as cyclosporine A or
FK506 [17]. The prolonged retention of Coronin-1 in
p h a g o s o m ed u r i n ga c t i v ei n f ection has been attributed
to a secreted mycobacterial lipoamide dehydrogenase C
(LpdC), which retains Coronin-1 on the phagosomal
membrane [18] and is produced only by live BCG and
M. tuberculosis.
Also, recent data have shown that inbred mice expres-
sing the Ipr1 (intracellular pathogen resistance 1) gene
in the sst1 locus were protected against infection by
M. tuberculosis and M. bovis. The up-regulation of Ipr1
after infection by M. tuberculosis limits the infection in
tuberculosis resistant mice by switching the cell death
pathway of the infected macrophages from necrosis to
apoptosis [19]. Sp110 is the closest human homologue
of Ipr1 gene and is located on chromosome 2 (2q37,1).
Sp110 is a component of the nuclear body, a multi-pro-
tein complex assumed to participate in the regulation of
gene transcription. This gene is very important for
monocytes’ differentiation, apoptosis and activation
including the response to pathogens [20,21]. Sp110 inhi-
bits vesicular stomatitis and influenza virus replication.
It also confers resistance to human Foamy virus, while
gene polymorphisms or mutations have been associated
with susceptibility to hepatitis C, immunodeficiency
v i r u sa n dh e p a t i cv e n o - o c c l u s i v ed i s e a s e[ 2 2 , 2 3 ] .I nt h i s
respect, Sp110 may also have a role in human tubercu-
losis infection.
Studies conducted so far, support the idea that intra-
cellular factors like Coronin-1, Sp110 and TLRs play a
decisive role in the progression of TB infection, at least
in experimental tuberculosis. Hence, it is possible, that
the expression of these molecules somehow regulates
the intracellular fate of M. tuberculosis through a com-
plicated cascade of up- and down-regulations. However,
studies regarding the expression of these intracellular
molecules in humans are lacking. We hypothesized that
during active infection, because of the turnover of the
infected monocytes and the following haematogenous
spread of the infection, these markers could be
increased in patients with TB.
The purpose of this study was to investigate the
expression of these molecules in peripheral blood mono-
nuclear cells and to look for any possible correlations
between their level of expression and the disease status.
We utilized a real-time PCR assay to measure the
expression of mRNA encoding Coronin-1, Sp110 and
TLRs in fresh whole blood cells of TB patients, close
contacts to patients that had latent infection (Quanti-
feron positive, QFT (+)), close contacts to patients with
no latent infection (Quantiferon negative, QFT (-)) and
a negative control population. QFT testing was
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recommendations in all circumstances in which the TST
is currently used, including contact investigations, eva-
luation of recent immigrants, and sequential-testing sur-
veillance programs for infection control (e.g., those for
healthcare workers) [24-26].
We demonstrated striking changes in the expression
of Coronin-1, Sp110 and TLR-2, between the TB-
infected population (actively and latently infected) com-
pared to the uninfected controls, whereas the levels of
the other TLRs did not differ significantly. Our data
s u g g e s tt h a tC o r o n i n - 1 ,S p 1 1 0a n da tl e a s tT o l l - l i k e
receptor-2 molecules are involved in the infectious pro-
cess of tuberculosis. However, their significance and




Twenty two patients with pulmonary tuberculosis (TB)
(group A) were recruited at the “Sotiria Hospital”,
Athens (Greece). Patients’ characteristics are shown in
Table 1. Sixteen patients had pulmonary cavitary disease
and or parenchymal TB, four patients pulmonary TB
and TB lymphadenitis and two patients had concomi-
tantly pulmonary disease associated with TB pericarditis
and TB pleural effusion, respectively. The diagnosis of
tuberculosis was confirmed by smear and culture posi-
tive for M. Tuberculosis from the respective biological
specimens.
Fifteen volunteers from the close contacts of patients,
that were tested positive for Quantiferon-TB (QFT),
after an extensive examination to exclude tuberculosis,
were considered to have LTBI and constituted the
group B. Seventeen volunteers from the close contacts,
that were tested negative for Quantiferon-TB in two
consecutive examinations (8-10 weeks apart from each
other) were considered not infected (group C). QFT
testing was used for diagnosis of LTBI because of its
greater specificity compared to intrademal Mantoux test
according to the recent CDC recommendations for the
investigation of contacts with an infectious case of
tuberculosis [27].
The exposure time for close contacts identification, i.e
the average daily exposure in hours multiplied by the
days of exposure, during the last trimester preceding the
tuberculosis diagnosis was also estimated according
these CDC guidelines [27]. This estimation of exposure
has also been validated in studies correlating the time
exposure to an index case with the performance of the
interferon gamma releasing assays (IGRAS) test [28].
The mean value of the average exposure time for close
contacts with latent TB infection (QFN positive) was
665.6 hour-days, while for the close contacts negative
for latent TB infection (QFN negative) was 648.82 hour-
days.
Finally, ten healthy volunteers with no exposure to
TB, matched for the age and gender were included, after
tested negative for QFT.
Informed consent was obtained from all patients, close
contacts to patients and control subjects, and the study
was approved by the Ethical Review Committee of
“Sotiria Hospital”.
Blood collection, RNA isolation, quantitative RT-PCR
Whole blood (2.5-5 ml) was drawn before or within the
first week of anti-TB treatment and was immediately
processed to prevent unwanted changes in RNA profile.
Total RNA was extracted from 10
6 human peripheral
blood nucleated cells (PBMCs) using the QIAamp® RNA
Blood mini kit (QIAGEN, GmBH), following the manu-
facturer’s instructions. The RNA samples were stored in
40 μl of RNAse free distilled water at -40°C. The relative
expression of Coronin-1, Sp110, TLR-1, TLR-2, TLR-4
and TLR-6 mRNAs was evaluated by quantitative real
time reverse transcription PCR with the one step RT-
PCR kit Light Cycler® RNA Master HybProbe (ROCHE).
Transcripts of b2 microglubin were initially quantified as
endogenous RNA of reference gene to normalize each
sample. However, because of the previously described
instability of the above mentioned mRNA during MTB
infection [29,30], we repeated the experiments using the
human acidic ribosomal protein (HuPO) as a reference
gene, that has been reported to remain stable during
tuberculosis infection [31,32]. Indeed, we noticed (data
not shown) a significant difference in our results regard-
ing at least two of the genes analyzed. The results pre-
sented in this study refer to the human acidic ribosomal
protein HuPO as the control gene. Taqman primers &
probe combinations used for TLRs were designed
according to a previous publication [33]. TIB MOLBIOL
Syntheselabor, GmbH designed and produced the pri-
mers and probes used for detection of b2 microglubin
(forward primer: CCAgCAgAgAATggAAAgTC, reverse
primer: gATgCTgCTTACATgTCTCg, probe FL:
Table 1 Characteristics of the patients with active TB
(group A), of the close contacts with latent TB infection
(group B), of the close contacts without latent TB
infection (group C), and of the control subjects (group D)






A [22] 43 ± 3 19/3 18/4
B [15] 43 ± 5 12/3 15/0
C [17] 35 ± 3 9/8 0/17
D [10] 35 ± 6 5/5 0/10
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LC: LC640-ATgAAACCCAgACACATAgCAATTCAg–
PH), Coronin-1 (forward primer:CAATCCggTACTTT-
gAgATCA, reverse primer: gCTTgTAgAACCTggCgA,
probe FL: CTCCTTggAACTgAACATggAgAgA-FL,
probe LC: LC640-AgTgCAggAAAggggCCTCg–PH),
Sp110 (forward primer: TCAgAggAgATCATTgATggC,
reverse primer: CACTTggAgCTTCTCTTggAT, probe
FL: AAAgAggTCCCAgAAgACgCCT–FL, probe LC:
LC640-gTACACCACgAAgggTCACACAAggg–PH) and
HuPO mRNA (forward primer: gCTTCCTggAgggTgTC,
reverse primer: CCAAgAAggCCTTgACCTT, probe FL:
CgAgTCCTggCCTTgTCTgTggA-FL, probe LC: LC640-
CggATTACACCTTCCCACTTgCTg–PH). All primers
and probes were stored at a concentration of 20 μM
and 10 μM, respectively. In b2 microglubin, Coronin-1
and Sp110 reactions, 0.5 μM of each forward and
reverse primer as well as 0.2 μMo ft h ep r o b e sw e r e
used per 20 μl reaction, while in Toll-like receptors
reactions the concentration of primers and probe were
0.5 and 0.1 μM, respectively. The PCR conditions were
as follows: 61°C for 20 min (RT), 95°C for 1 min
(DENATURATION), 95°C for 3 sec, 54°C(50°C for
SP110/HuPO and 48°C for coronin) for 12 sec, 72°C for
10 sec (45 cycles), 95°C for 0 sec, 50°C(48°C for SP110/
HuPO and 46°C for coronin) for 30 sec, gradually up to
80°C for 0 sec (MELTING CURVE), 40°C for 30 sec
(COOLING).
Data analysis
T h eW i l c o x o nt e s tf o rt h ed i f f e r e n c eo fd e p e n d e n ta n d
the Mann-Whitney-Wilcoxon test for the difference of
independent means of the variables examined were used
for the analysis in the present study. Correlation
between the expressions of the variables examined
within the different groups was calculated according to
Spearman cofactor for linear correlation. The analysis
was contacted using SPSS program version 16.0 for
Windows.
Results
Effect of tuberculosis infection on the expression of
immunity markers
The comparison of mRNA levels (divided by the expres-
sion of the reference gene expression) of the different
intracellular molecules examined between the various
groups of our study is shown in Table 2 and separately
for each factor in Figures 1, 2. Compared with the unin-
fected population (groups C and D), whole blood from
patients (group A) and from latently infected subjects
(group B) had significantly increased levels (p < 0.05) of
mRNA encoding Coronin-1, Sp110 and TLR-2. In con-
trast, expression of Coronin-1, Sp110 and TLR-2
mRNAs were not significantly different between the
patients (group A) and the close contacts with latent
infection (group B). TLR-1 mRNA was not significantly
increased in TB-patients (group A) vs uninfected
subjects (group C and D), while TLR-4 and TLR-6
mRNAs were significantly increased (p < 0.05) only
between actively infected patients (group A) and
qcontrols (group D).
Correlation between the markers’ expression in PBMCs
with the infection state
According to the Spearman cofactor for linear correla-
tion, there was a positive correlation between Coronin-1
and Sp110 (r = 0.603), Coronin-1 and TLR-2 (r = 0.615)
and between Sp110 and TLR-2 (r = 0.654) expression in
the patients group (group A) and close contacts group
with LTBI (group B) (Figure 3). By contrast, no signifi-
cant correlation was found between the expression of
these markers in the uninfected group of close contacts
(group C) and in the control subjects (group D) (data
not shown).
Discussion
In this study, we observed an increased expression of
TLR-2, Coronin-1, and Sp110 mRNA levels in PBMCs
of patients with tuberculosis and in close contacts of
patients that had latent tuberculosis infection. Further-
more, we found an increased expression of TLR-2
mRNA in patients with tuberculosis compared to the
close contact group without LTBI, whereas there was no
significant difference in the expression of TLR-2 mRNA
between patients and close contacts with LTBI. These
findings indicate that TLR-2 Coronin-1, and Sp110 are
probably involved in the infection process of human
tuberculosis.
TLRs have been reported to participate in the interac-
tions of pathogenic mycobacteria or their extracellular
products with mouse and human cells [34]. In particu-
lar, TLR-2 in association with TLR-1 and TLR-6, and
TLR-4 have been implicated as receptors involved in the
recognition of mycobacterial antigens and activation of
macrophages and dendritic cells [35]. In a recent study,
an increased expression of TLR-1, TLR-2, TLR-4 and
TLR-6 has been reported at the mRNA level in periph-
eral blood mononuclear cells, but not in broncho-alveo-
lar lavage cells from patients with tuberculosis
compared to healthy controls [36]. The high expression
of TLR-2 in PBMCs can be explained by increased cir-
culating levels of pro-inflammatory cytokines or by cir-
culating mycobacteria/mycobacterial components.
Alternatively, it may simply represent the re-circulating
monocytes from the pulmonary tuberculous granulomas,
which are expressing TLR-1, TLR-2 and TLR-4, as pre-
vious studies have shown [37]. Accumulating data indi-
cate that Mycobacterium tuberculosis expresses a large
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(LpqH), lipoproteins LprA (Rv1270) and LprG
(Rv1411c). Lipomannan and phosphatidyl-myo-inositol
mannoside (PIM) are also TLR-2 agonists, which inter-
act with TLR-2 to initiate cellular activation. The 19-
kDa lipoprotein (LpqH), secreted by MTB, was the first
MTB ligand, which has been shown to interact specifi-
cally with TLR-2 to induce TNF-a and nitric oxide pro-
duction in both murine and human macrophages. It is
also a major inducer of interleukin-12 production in
human monocytes [38]. Furthermore, it has been shown
that TLR-2 is essential for the intracellular mycobacter-
ial killing in macrophages, through the production of
the antimicrobial peptide cathelicidin, an effect mediated
by a vitamin-D related pathway [10]. However, studies
in mice have shown that TLR-2 is not essential for host
resistance against tuberculosis infection since the TLR-
2-deficient mice were not compromised in their ability
to induce Th1 immunity. On the contrary, it did exhibit
exaggerated immuno-pathology. Additional in vitro stu-
dies have shown that engagement of TLR-2 with MTB
ligands induces inhibition of macrophage MHC class-II
antigen presentation [39] and also blocks macrophage
responsiveness to IFN-g [40,41]. These diverse data indi-
cate that further studies are needed to elucidate whether
TLR-2 is beneficial or harmful in humans in regard to
tuberculosis.
The increased expression of Coronin-1, a protein that
specifically inhibits the intracellular killing of live myco-
bacteria in mononuclear cells, is probably due to a spe-
cific subset of inactivated immature monocytes, which
act as a Trojan horse for carrying mycobacteria from
the inoculation sites to the other compartments of the
cell body. However, although occult haematogenous dis-
semination is thought to occur following initial infection
of humans with MTB, there is no direct evidence of this
in the present study. The results observed here are
rather consistent with recirculation of activated mono-
cytes from the site of the infection.
This represents the well known process of haemato-
genous spread of tubercle bacilli during MTB infection
via blood vessels and lymphatics, which involves the
Table 2 Primers and probes sequences for Real Time RT-PCR of b2 microglubin, Coronin-1, HuPO and SP110 mRNA








Coronin-1 CAATCCggTACTTTgAgATCA gCTTgTAgAACCTggCgA CTCCTTggAACTgAACATggAgAgA-FL LC640-AgTgCAggAAAggggCCTCg–PH
SP110 TCAgAggAgATCATTgATggC CACTTggAgCTTCTCTTggAT AAAgAggTCCCAgAAgACgCCT–FL LC640-
gTACACCACgAAgggTCACACAAggg–
PH
HuPO gCTTCCTggAgggTgTC CCAAgAAggCCTTgACCTT CgAgTCCTggCCTTgTCTgTggA-FL LC640-
CggATTACACCTTCCCACTTgCTg–PH
Figure 1 Expression of mRNA encoding for Coronin-1 and Sp110 in fresh unstimulated whole blood in the various groups studied.
Data were normalized relative to the endogenous expression of the human acidic ribosomal protein HuPO. There was no significant difference
in Coronin-1 and Sp110 expression (p > 0.05) between the patients’ group (group A) and positive close contacts’ group (group B). *p < 0.05, for
Groups A and B as compared with the uninfected population (groups C and D).
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lous lesions and the blood, a process that peaks during
the phase of active infection [1,42]. Furthermore, during
MTB infection, activated macrophages ingesting micro-
organisms generate phagosomes that mature progres-
sively along with the endocytic pathway, leading to
fusion with late endosomes and ultimately to the forma-
tion of lysosomes [43,44]. As a result, the proper orches-
tration of these events leads to the destruction of the
pathogen in phagolysosomes and the initiation of the
appropriate innate immune response [45,46]. In striking
contrast, the failure of phagosomes to fuse with lyso-
somes is a frequent finding following macrophage inges-
tion of Mycobacterium tuberculosis (MTB) and the
variant M. bovis BCG, enabling these organisms to
reside safely in vacuoles that support their survival and
replication [31,32,47]. Since Coronin-1 is up-regulated
in patients with tuberculosis infection (i.e.p a t i e n t sa n d
LTBI close contact group) it is possible that Coronin-1
may have a role as a marker of MTB infection before
the occurrence of the disease. Until now the diagnosis
of tuberculous infection is based mostly on immunologi-
cal tests such as the tuberculin skin test and the inter-
feron gamma releasing assays (IGRAS). However, these
tests are informative about the immunological status of
an individual to mycobacterial antigens and are not
helpful in distinguishing an active infection; therefore
specific markers of the infection status are highly desir-
able [48,49].
Surprisingly, we have also observed an increased
expression of Sp110 in the MTB infected groups (active
TBC patients and LTBI groups) compared to non-
infected closed contacts and the healthy population.
However, three recently published molecular studies
reported that there is no association between human
pulmonary tuberculosis and Sp110 gene polymorphisms
[50,51]. On the contrary, a previous study has reported
an association of Sp110 polymorphisms with susceptibil-
ity to tuberculosis in West Africa [52]. The increased
expression of Coronin-1 and Sp110 in the infected
groups suggests that Sp110 may have a diverse role in
humans compared to mice during MTB infection. It was
Figure 2 TLR-1 (a), TLR-2 (b), TLR-4 (c), TLR-6 (d) in fresh unstimulated whole blood in the various groups studied.D a t aw e r e
normalized relative to the endogenous expression of the human acidic ribosomal protein HuPO. There was no significant difference between
groups A and B (p > 0.05) in a,b,c, and d. (a)*p < 0.05, for Groups A and B as compared with the uninfected population (groups C and D).
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replication of intracellular pathogens, as in A. phagocyto-
philum, an obligate intracellular tick-borne pathogen
that causes human granulocytic anaplasmosis (HGA) in
HL-60 cells, while silencing of Sp110 expression by
RNA interference results in decreased levels of infection
[53]. Thus, the role and function of Sp110 in human
pulmonary tuberculosis needs further investigation.
In our study, we found a strong correlation between
Coronin-1 and TLR-2 expression in nucleated blood
cells of infected patients compared to the non-infected
groups. Recent data point out a link between TLR-2 and
calcineurin, which is the final effector molecule of pha-
gosome-lysosome fusion in the Coronin-1 pathway.
Activation of TLRs generally leads to nuclear transloca-
tion of the transcription factor NF-B, a critical compo-
nent within many proinflammatory pathways, [16]
including those associated with chemokine gene expres-
sion [10]. Although TLRs share the ability to activate
NF-B, cross talk with other signalling pathways is one
mechanism by which activation of specific TLRs may
lead to different patterns of gene expression [35].
Another key signalling molecule of the immune
response, calcineurin, has been reported to have a func-
tional interaction with NF-B [54]. In two recently pub-
lished studies it has been suggested that calcineurin may
play a predominant role in the mediation of TLR-2-sti-
mulated chemokine responses in murine myoblasts and
in human airway epithelial cells, [55,56] indicating that
Coronin-1 is a down-stream molecule in the TLR-2
pathway cytokine activation. In this regard it is possible
that TLR-2 signalling pathway mediates the Coronin-1
expression and thus facilitates the intacellular survival of
Mycobacterium tuberculosis in human PBMCs. How-
ever, recent studies suggest a negative relation between
TLR-2 and Coronin-1, because TLR-2 is essential for
the transformation of the inactive vitamin-D3 to its
active form and promotes the production of cathelicidin,
Figure 3 Spearman correlations between the expression of Coronin-1 and Sp110 (a), Coronin-1 and TLR-2 (b), and TLR-2 and Sp110
(c) mRNA expression in the patients’ (group A) and the positive close contacts (group B) groups.
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Furthermore, pre-treatment of human monocytes with
vitamin- D3/retinoic acid, down-regulated the expression
of Coronin-1 and inhibited the entry and intracellular
survival of M. tuberculosis within the monocytes [57].
A recent report from Japan also suggested a functional
counteraction between TLR-2 and Coronin-1 in macro-
phages infected with Mycobacterium leprae [58]. Thus,
although the data in this report regarding the TLR-2
and Coronin-1 interplay in M. tuberculosis infection
need further elucidation, there is actual evidence to sup-
port a possible positive and negative feedback functional
relation between them.
The strong correlation between Sp110 with TLR-2
expression in PBMCs in infected patients compared to
the non-infected groups suggests that Sp110 expression
is mediated through a TLR-2 pathway. TLRs activation
generally leads to nuclear translocation of the transcrip-
tion factor NF-B. Sp110 is a member of the nuclear
body (NB) components that functions as a nuclear hor-
mone receptor transcriptional co-activator [19]. Sp110
and other NB-associated proteins, induced by type I (a/
b) and type II (g) interferons (IFNs), play a role in IFN
response and virus replication. Sp110 expression is
induced in human peripheral blood leukocytes and
spleen but not in other tissues [22]. These data indicate
that the expression of Coronin-1 and Sp110 is probably
related to a TLR-2 activation pathway. However, further
studies are needed to clarify this assumption. A compar-
ison with other well-known genes associated with
immune activation (e.g. TNF) might better elucidate this
hypothesis.
Conclusions
In conclusion, in the present work we have shown that
mRNA levels of Coronin-1, Sp110 and TLR-2 are
increased in patients with tuberculosis and in close con-
tacts of patients with latent tuberculosis infection.
Although our patient cohort sample was not particularly
large our findings suggest that these molecules are
essential for the disease process. However, further stu-
dies are needed to investigate the clinical significance of
these markers in M. tuberculosis infection.
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